Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Neogen (NEOG) EBT Margin (2016 - 2025)

Historic EBT Margin for Neogen (NEOG) over the last 16 years, with Q4 2025 value amounting to 9.06%.

  • Neogen's EBT Margin rose 1970100.0% to 9.06% in Q4 2025 from the same period last year, while for Nov 2025 it was 70.14%, marking a year-over-year decrease of 149500.0%. This contributed to the annual value of 126.65% for FY2025, which is 1251000.0% down from last year.
  • As of Q4 2025, Neogen's EBT Margin stood at 9.06%, which was up 1970100.0% from 20.94% recorded in Q3 2025.
  • In the past 5 years, Neogen's EBT Margin ranged from a high of 20.94% in Q3 2025 and a low of 279.96% during Q2 2025
  • In the last 5 years, Neogen's EBT Margin had a median value of 0.15% in 2023 and averaged 21.23%.
  • Over the last 5 years, Neogen's EBT Margin had its largest YoY gain of 1970100bps in 2025, and its largest YoY loss of -2772600bps in 2025.
  • Neogen's EBT Margin (Quarter) stood at 9.91% in 2021, then crashed by -250bps to 14.82% in 2022, then skyrocketed by 89bps to 1.63% in 2023, then tumbled by -12529bps to 206.08% in 2024, then soared by 96bps to 9.06% in 2025.
  • Its EBT Margin was 9.06% in Q4 2025, compared to 20.94% in Q3 2025 and 279.96% in Q2 2025.